The market roared, but the pros did not tag along in size. They either have to catch up, or they are just not coming.
My main strategy now is short-term trades and very small incremental buys for the longer term.
All the indexes are in near-term downtrends -- except for one.
Despite doom and gloom and negative technical patterns, there is positive action early Wednesday.
Here's what charts and data are telling us.
I am more concerned, for markets, about quantitative tightening than rate hikes.
The march toward positive real yield territory has put the whammy on equities, primarily on tech or "growthy" type stocks that have run at higher valuations.
These recently downgraded names are displaying both quantitative and technical deterioration.
After receiving an FDA approval, the small-cap biotech looks well positioned as a covered call candidate.
There are certain sectors of the stock market where rising rates create tailwinds for earnings.